Ophthalmic Equipment Market Drive Due To Rising prevalence of eye diseases
Luton, Bedfordshire, United Kingdom, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Exactitude Consultancy, the market research and consulting wing of Ameliorate Digital Consultancy Private Limited has completed and published the final copy of the detailed research report on the Ophthalmic Equipment Market.
The global Ophthalmic Equipment Market size is USD 52.80 billion in 2020 and is expected to grow to USD 75.14 billion by 2029, at a Compounded annual growth rate (CAGR) of 4.20%.
Medical procedures and elective surgeries have also been subjected to restrictions and bans by governments. The need for ophthalmic equipment has been limited by these limits. Ophthalmic equipment manufacturers are having difficulty giving in-person product presentations, working at full capacity, and attending or organising conferences as a result of these restrictions. Lockdowns in APAC countries like China and India have caused ophthalmic equipment production and shipment to be delayed. All of these challenges make the growth of the ophthalmic equipment market difficult.
Over 2 million persons in the United Kingdom were blind in 2013, according to the Royal National Institute of Blind Persons (RNIB), with that number expected to climb to 4.1 million by 2050. Demand for precision disease treatment is expected to rise in the coming years as the prevalence of eye illnesses rises, resulting in an increase in disability-adjusted life years (DALYs). As a result, global demand for ophthalmic equipment will increase.
Get Exclusive PDF Sample Copy of Ophthalmic Equipment Market Report: https://exactitudeconsultancy.com/reports/6441/ophthalmic-equipment-market/#request-a-sample
Overview: In February 2020, to raise awareness about AMD, Bausch + Lomb (Canada) cooperated with Prevent Blindness (US) using social media platforms to share information with the public.
In May 2020, Bausch + Lomb (Bauer + Lomb) LuxSmart, the company’s first EDOF IOL, and LuxGood, a monofocal IOL with a preloaded delivery system and pure refractive optics (PRO) technology, were introduced.
Overview: In April 2020, Haag-Streit Group (Switzerland) bought VRmagic Holding AG (Germany) to bolster Haag-ophthalmology Streit’s market leadership.
Regional outlook- Asia pacific currently dominates this market and is expected to remain so for the foreseeable future. According to the United Nations Economic and Social Affairs Report (2019), Asia population of people aged 65 and older is expected to increase from 395.3 million in 2019 to 587.4 million by 2030, leading to an increase in the prevalence of age-related eye diseases. Glaucoma affects around 3.5 percent of those over the age of 45 in China, although it climbs substantially with age, reaching over 9 percent in the population over 65. Similarly, as the prevalence of diabetes rises in India, so does the number of cases with age-related macular degeneration (AMD).
Ophthalmic Equipment Market- Growing competition among key players, increasing horizontal and vertical expansion is further expected to fuel the growth of Ophthalmic Equipment Market.
The Key Players in Ophthalmic Equipment are essilorluxottica, Alcon, Johnson & Johnson Vision Care, HOYA Corporation, Bausch + Lomb, Carl Zeiss Meditec, Topcon, Glaukos Corporation, Haag-Streit, NIDEK, STAAR Surgical, Ziemer Ophthalmic Systems, coopervision, Inc, and others. Ophthalmic Equipment Market Scope and Segmentation
Ophthalmic Equipment Market Regions Covered
Ophthalmic Equipment by Product, 2020-2029 (USD Millions) (Millions Unit)
Specialty Clinics And Ambulatory Surgery Centres
Yes, the report can be customized as per your need. (Free 15% Customization)
Browse Detailed Research Insights with TOC: https://exactitudeconsultancy.com/reports/6441/ophthalmic-equipment-market/
Leading businesses are concentrating on increasing their market share.
The market’s top players have made significant investments in both research and development and production. The top leaders’ expansion plans include product offers that are backed up by excellent operational efficiency and cutting-edge technology. They’ve all emphasised the need of well-established supply chains. Leading firms are producing new products and purchasing small-scale producers or suppliers to strengthen their market position and remain ahead of the competition.
What are the Ophthalmic Equipment Market factors that are explained in the report?
Ophthalmic Equipment Market Estimates and Forecasts (2022-2029)
Key Drivers and Restraints Shaping Market Growth
Segment-wise, Country-wise, and Region-wise Analysis
Brand Share and Market Share Analysis
Key Product Innovations and Regulatory Climate
COVID-19 Impact on Demand for Ophthalmic Equipment and How to Navigate
Recommendation on Key Winning Strategies
Quick Buy - Ophthalmic Equipment Market Research Report: https://exactitudeconsultancy.com/reports/6441/ophthalmic-equipment-market#inquire-for-discount
Browse More Research Topic on Healthcare Industry:
The global ventilators market is expected to grow at more than 7.6% CAGR from 2022 to 2029. It is expected to reach above USD 2.5 billion by 2029 from USD 1.3 billion in 2020.
The global pulse oximeter market will witness a CAGR of 9.3% for the forecast period of 2022-2029. It is expected to reach above USD 5.01 Billion by 2029 from USD 2.25 Billion in 2020.
Bill Gates looks for income, too. This is how he gets it.
The market rally has revived, but watch out for Treasury yields. Elon Musk made a new move vs. Twitter. Warren Buffett bought more OXY stock.
In this article, we discuss the 10 best energy stocks to buy now. If you want to skip our industry overview, take a look at the 5 Best Energy Stocks to Buy Now. The Covid-19 pandemic was difficult for the energy sector. Global travel restrictions brought on by the Covid-19 outbreak reduced demand for oil […]
SINGAPORE (Reuters) -Oil prices fell on Monday with the global fuel demand outlook overshadowed by COVID-19 restrictions in China and the potential for further interest rate hikes in the United States and Europe. Brent crude futures dropped $1.28, or 1.4%, to $91.56 a barrel by 0330 GMT, after settling 4.1% higher on Friday. Prices were little changed last week as gains from a nominal supply cut by the Organization of the Petroleum Exporting Countries (OPEC) and allies including Russia, a group known as OPEC+, were offset by ongoing lockdowns in China, the world's top crude importer.
Among six high-profile stock splits -- Alphabet, Amazon, Tesla, Shopify, DexCom, and Palo Alto Networks -- is a clear-cut bargain, as well as a company with serious red flags.
Nio (NYSE: NIO) is a leading player in China's electric vehicle (EV) market and has sometimes been referred to as the "Chinese Tesla." Should investors treat Nio's big valuation pullback as an opportunity to build a position in the stock, or is the EV company's share price still too high to generate strong returns? Howard Smith: Nio's recently released quarterly earnings report provided a good lesson for investors wanting to log big returns on more speculative, high-growth companies.
Tough times ahead. But you don't need to sell it all.
Berkshire Hathaway's (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett is one of the best investors of our lifetime. Buffett stands out, in part, because he doesn't tend to follow the crowd, doesn't fear market crashes, and has a knack for putting his cash to work when everyone else is fearful. Buffett has explained that he looks to buy quality companies with management teams he likes and that he buys with the intention of holding on to these investments for years or even decades.
In today's volatile market, there's a lot to be said for seeking out boring businesses at cheap prices.
There's a bond that pays a 9.62% interest rate and is guaranteed by the U.S. Treasury. Investors should keep some limitations and conditions in mind before investing, but as inflation has topped 8% since March 2022, this could be an … Continue reading → The post Want 9.62% Yield Guaranteed? Seriously, Try This Asset appeared first on SmartAsset Blog.
During tricky market conditions, it can be helpful to follow professional investors who are focused on the long term.
Warren Buffett's Berkshire Hathaway disclosed its Occidental Petroleum stake has risen to 26.8%. OXY stock rose slightly late Friday.
If you want to secure a decent yield, it can pay to buy shares of strong companies dealing with short-term problems.
The biotech sector, like most sections of the market, took a sound beating in the year’s first half. Recently, however, the segment’s performance has improved, and that has helped the NASDAQ Biotechnology Index (NBI) pull ahead of the NASDAQ (Up 13% over the past 3 months vs. the NASDAQ’s 3%). The Oppenheimer biotech team thinks there’s a simple explanation for this: “We believe that much of the recent outperformance has been driven by SMID caps, of which many have risen admirably in the past fe
With Teekay leading the pack, these are the 5 biggest oil tanker companies by 12-month trailing revenue.
The disappointing performance of the stock market has a silver lining, which is that dividend yields are rising across the market. Many stocks that had low dividend yields due to their soaring stock prices have seen their dividend yields elevate. The following three large-cap stocks have strong business models, leadership positions in their industry, and have high dividend yields above 4%.
Building an excellent stock portfolio is a lot like making a fantastic meal. If I only had three stocks to choose from and $50,000 to invest, the following would be my top three stocks to buy: Amazon (NASDAQ: AMZN), Lululemon (NASDAQ: LULU), and Chevron (NYSE: CVX). The first two are growth plays and Chevron adds value to the portfolio.
The stock market rally is reviving, but is even stronger than the major indexes suggest. Tesla is among stocks in buy areas.
DocuSign (NASDAQ: DOCU) is one of those companies. As a result, investors have sent DocuSign stock plunging 81% from its all-time high. The company just reported its financial results for the second quarter of fiscal 2023 (ended July 31), and not only did it show a healthy jump in sales, but DocuSign also expressed renewed enthusiasm by increasing its full-year guidance.
These fast-paced companies have the innovative capacity to make you a millionaire over the next seven years.